Megan Null

5PUBLICATIONS

29CO-AUTHORS

Innate immunityMedical molecular engineering of nucleic acids and proteinsMajor global burdens of diseaseSub-acute careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 29, 2026

Human neonatal MR1T cells have more diverse TCR repertoires but reduced bacterial recognition than adult MR1T cells.

|Apr 16, 2025

Human Neonatal MR1T Cells Have Diverse TCR Usage, are Less Cytotoxic and are Unable to Respond to Many Common Childhood Pathogens.

Deborah A Lewinsohn, Dylan Kain, Wael Awad

|Apr 09, 2025

A narrative review of the pathophysiology of sepsis in sub-Saharan Africa: Exploring the potential for corticosteroid therapy.

Phoebe Gruccio, William S Girard, Amelia D Badipour

|Oct 22, 2024

The Universal Vital Assessment (UVA) score at 6 hours post-resuscitation predicts mortality in hospitalized adults with severe sepsis in Mbarara, Uganda.

Megan Null, Mark Conaway, Riley Hazard

|Feb 24, 2024

Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.

Corinna A Kulicke, Gwendolyn M Swarbrick, Nicole A Ladd

Pageof 1

Frequent Collaborators

Gwendolyn Swarbrick

David M Lewinsohn

Dylan Kain

Wael Awad

Katherine Rott

Jamie Rossjohn

Benjamin N Bimber

Christopher C Moore

G W McElfresh

Kean Chan Yew Poa

Frequent Collaborators

Gwendolyn Swarbrick

David M Lewinsohn

Dylan Kain

Wael Awad